US Life Sciences Market Segmentation
Life Sciences By Type (USD Billion, 2025-2035)
- Nucleoside
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Integrase Inhibitors
- Fusion Inhibitors
- CCR5 Antagonists
Life Sciences By End User (USD Billion, 2025-2035)
- Hospitals & Clinics
- Specialty Centers